R. C. Dardes

493 total citations
17 papers, 391 citations indexed

About

R. C. Dardes is a scholar working on Genetics, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, R. C. Dardes has authored 17 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 4 papers in Oncology and 4 papers in Obstetrics and Gynecology. Recurrent topics in R. C. Dardes's work include Estrogen and related hormone effects (14 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cancer Risks and Factors (2 papers). R. C. Dardes is often cited by papers focused on Estrogen and related hormone effects (14 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cancer Risks and Factors (2 papers). R. C. Dardes collaborates with scholars based in Brazil, United States and United Kingdom. R. C. Dardes's co-authors include V. Craig Jordan, David J. Bentrem, Ruth O’Regan, Hong Liu, James Zapf, Csaba Gajdos, Gil Facina, G. Rodrigues de Lima, Luíz Henrique Gebrim and Jennifer MacGregor Schafer and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Endocrinology and European Journal of Cancer.

In The Last Decade

R. C. Dardes

16 papers receiving 386 citations

Peers

Countries citing papers authored by R. C. Dardes

Since Specialization

Citations

This map shows the geographic impact of R. C. Dardes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. C. Dardes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. C. Dardes more than expected).

Fields of papers citing papers by R. C. Dardes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. C. Dardes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. C. Dardes. The network helps show where R. C. Dardes may publish in the future.

Co-authorship network of co-authors of R. C. Dardes

This figure shows the co-authorship network connecting the top 25 collaborators of R. C. Dardes. A scholar is included among the top collaborators of R. C. Dardes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. C. Dardes. R. C. Dardes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Clinical and histomorphometric evaluation of the vagina following treatment with CO2 laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy 2024 ·Maturitas ·(unknown), (unknown), (unknown), Marcela Fernandes, (unknown), R. C. Dardes, Ângela Flávia Logullo, (unknown), Gil Facina, Zsuzsanna Ilona Katalin de Jármy Di Bella, Marair Grácio Ferreira Sartori, (unknown)	0
2	Alcohol Consumption as a Risk Factor for Breast Cancer Development: A Case-Control Study in Brazil 2018 ·PubMed ·(unknown), (unknown), R. C. Dardes, Luiz Cláudio Santos Thuler, (unknown)	14
3	Potential of endogenous estrogen receptor β to influence the selective ER modulator ERβ complex 2005 ·International Journal of Oncology ·Bin Chen, Csaba Gajdos, R. C. Dardes, (unknown), (unknown), Mitch Dowsett, Vanessa Jordan	6
4	Effects of low dose tamoxifen on normal breast tissue from premenopausal women 2003 ·European Journal of Cancer ·G. Rodrigues de Lima, Gil Facina, (unknown), (unknown), (unknown), R. C. Dardes, V. Craig Jordan, Luíz Henrique Gebrim	69
5	Regulation of Estrogen Target Genes and Growth by Selective Estrogen-Receptor Modulators in Endometrial Cancer Cells 2002 ·Gynecologic Oncology ·R. C. Dardes, (unknown), Sandra Timm Pearce, Clodia Osipo, (unknown), V. Craig Jordan	42
6	Effects of Raloxifene After Tamoxifen on Breast and Endometrial Tumor Growth in Athymic Mice 2002 ·JNCI Journal of the National Cancer Institute ·Ruth O’Regan, Csaba Gajdos, R. C. Dardes, (unknown), Wonse Park, Alfred Rademaker, V. Craig Jordan	48
7	Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. 2002 ·PubMed ·R. C. Dardes, Ruth O’Regan, Csaba Gajdos, Simon P. Robinson, David J. Bentrem, Alex D. Reyes, V. Craig Jordan	32
8	Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice. 2001 ·PubMed ·R. C. Dardes, David J. Bentrem, Ruth O’Regan, Jennifer MacGregor Schafer, V. Craig Jordan	19
9	Molecular Mechanism of Action at Estrogen Receptor α of a New Clinically Relevant Antiestrogen (GW7604) Related to Tamoxifen*This work was supported by NIH CA-56143 (to V.C.J.); Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, (CAPES) Scholarship, Brazil (to R.D.); the U.S. Army Medical Research and Material Command Breast Cancer Research Program, DAMD17–96-16169 (to H.L.); the generosity of the Lynn Sage Breast Cancer Research Foundation of Northwestern Memorial Hospital; and the Avon Products Foundation. 2001 ·Endocrinology* ·David J. Bentrem, R. C. Dardes, Hong Liu, (unknown), James Zapf, V. Craig Jordan	75
10	Characteristics of raloxifene-stimulated breast tumors in vivo 2001 ·Ruth O’Regan, (unknown), R. C. Dardes, Csaba Gajdos, (unknown), S Badve, V. Craig Jordan	1
11	Raloxifene stimulated endometrial cancer grown in athymic mice: Cross resistance with ICI182,780 and antitumor action of estradiol 2001 ·R. C. Dardes, (unknown), Csaba Gajdos, Ruth O’Regan, (unknown), V. Craig Jordan	2
12	Effects of ICI 182,780 on tamoxifen-stimulated breast and endometrial cancer 2001 ·Csaba Gajdos, (unknown), R. C. Dardes, Ruth O’Regan, (unknown), (unknown), V. Craig Jordan	1
13	Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts. 2001 ·PubMed ·Jennifer MacGregor Schafer, (unknown), R. C. Dardes, David J. Bentrem, Ruth O’Regan, (unknown), V C Jordan	38
14	Modulation of estrous cycle and LH, FSH and melatonin levels by pinealectomy and sham-pinealectomy in female rats 2000 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·R. C. Dardes, Edmund Chada Baracat, Manuel de Jesus Simões	24
15	Novel agents to modulate oestrogen action 2000 ·British Medical Bulletin ·R. C. Dardes, V. Craig Jordan	16
16	Future directions in endocrine therapy for the treatment and prevention of breast cancer 2000 ·R. C. Dardes, V. Craig Jordan	2
17	P-36. Standardization of the Dose-Effect of Oral Estrogens and Progestogens in Adult Rats 1998 ·Menopause The Journal of The North American Menopause Society ·Edmund Chada Baracat, Manuel de Jesus Simões, José Maria Soares, R. C. Dardes, Ivaldo Silva, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact